FDA NDC Directory · JSON-LD · Markdown

Sodium Phenylacetate and Sodium Benzoate

NDC 70511-102 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerMAIA PHARMACEUTICALS
Marketing categoryNew Drug Application (innovator) · App NDA215025
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsSODIUM BENZOATE (100 mg/mL)
SODIUM PHENYLACETATE (100 mg/mL)
Marketing started20210701
Package count1

External sources

Source: openFDA. Public-domain (CC0).